Crossmark

Drugging p53 in cancer: one protein, many targets

Crossref DOI link: https://doi.org/10.1038/s41573-022-00571-8

Published Online: 2022-10-10

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hassin, Ori https://orcid.org/0000-0002-4959-9662
Oren, Moshe https://orcid.org/0000-0003-4311-7172
License Information

Text and Data Mining valid from 2022-10-10

Version of Record valid from 2022-10-10
More Information

Article History

Accepted: 6 September 2022

First Online: 10 October 2022

Competing interests

: M.O. consults for Quintrigen.